The Tübingen Center for Academic Drug Discovery (TüCAD 2 ), founded in 2012, is part of the University's excellence strategy. TüCAD 2 is closely connected to the Excellence Cluster iFIT, ICEPHA (Interfaculty Center for Pharmacogenomics) and to NCT-SW (National Center for Tumor Diseases-SouthWest) and focus on pharmacological validation of genetically identified targets. The strong translational focus brought four compounds until now “first into human”. An essential part of TüCAD 2 is a teaching concept, in which both a med chem curriculum and a MedChemCampus play a major part. Together with the GDCh Division of Medicinal Chemistry, TüCAD 2 started the MedChemCampus events in 2023, dealing with case studies, presented by eminent drug discovery experts from both industry and academia.
Topics: Case studies dealing with challenges in drug discovery
eg pharmacokinetics, structural biology, lead optimization, safety, selectivity, brain-penetrance, resistance, macrocycles
Target Audience
- Young professionals in drug discovery & medicinal chemistry (academia and industry)
- PostDocs and graduate students in medicinal chemistry
15/16 September 2025
Tübingen
website
October 10/11, 2023
Tübingen
Flyer
This page has been machine translated. If you have any feedback or comments please feel free to contact us.
last modified: 09.04.2025 18:59 H from Translator